Associate Attending
Memorial Sloan Kettering Cancer Center
New York, NY, United States
Dr. Ying Taur received his M.D. and M.P.H. from New York Medical College, completed internal medicine residency at Long Island Jewish Medical Center, and then completed infectious diseases fellowship training at Memorial Sloan Kettering Cancer Center in New York City. He has stayed on at MSKCC as faculty member in the Infectious Diseases Service, where he has continued to engage in clinical research and patient care.
Dr. Taur’s research has primarily involved study of the intestinal microbiome and its impact on susceptible patient populations such as those with cancer. He has overseen the collection of over 20,000 fecal biospecimens in immuncompromised patients at his institution, many of which consistent of recipients of allogenic hematopoietic stem cell transplantation. He has published numerous studies examining the importance and role of the intestinal microbiota in infections such as bloodstream infections from gut translocation, Clostridiodes difficile infection, and viral infection, as well as other outcomes such as graft-versus-host disease (GVHD) and transplant-related mortality. He was principal investigator in an investigator-initiated randomized trial of fecal microbiota transplantation in stem cell transplant recipients.
Disclosure(s): Seres Therapeutics: Advisor/Consultant
17 - These Blind Mice: When Bench Doesn't Meet Bedside
Monday, October 20, 2025
8:00 AM - 9:00 AM US ET
55 - Unmeasured Variables: Microbiome-Mediated Effects of Treatment Outcomes
Monday, October 20, 2025
8:30 AM - 9:00 AM US ET